Dianthus Therapeutics (DNTH) Assets Growth (3y) (2020 - 2025)

Dianthus Therapeutics (DNTH) Assets Growth (3y) (2020 - 2025) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 67,072.09 Bn 67,072.09 Bn -
2 Nanobiotix 1,894.61 Bn 1,894.55 Bn -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn -
4 BeOne Medicines 471.64 Bn 466.85 Bn 1.35 Bn
5 Vertex Pharmaceuticals 121.72 Bn 114.47 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 68.28 Bn 59.52 Bn 3.31 Bn
7 Belite Bio 61.40 Bn 61.40 Bn -
8 Argenx Se 56.94 Bn 56.94 Bn 1.18 Bn
9 Revolution Medicines 37.37 Bn 37.37 Bn -
10 Dianthus Therapeutics 3.92 Bn 3.51 Bn -

Historic Data

Download Data
DateValue
Dec 31, 2025 85.55%
Sep 30, 2025 52.09%
Jun 30, 2025 23.03%
Mar 31, 2025 21.49%
Dec 31, 2024 25.34%
Sep 30, 2024 19.76%
Jun 30, 2024 18.74%
Mar 31, 2024 38.29%
Dec 31, 2023 3.54%
Sep 30, 2023 3.29%
Jun 30, 2023 -25.57%
Mar 31, 2023 -16.72%
Dec 31, 2022 -19.87%
Sep 30, 2022 -2.53%
Jun 30, 2022 -3.59%
Mar 31, 2022 9.59%
Dec 31, 2021 6.48%
Sep 30, 2021 6.07%
Jun 30, 2021 6.86%
Dec 31, 2020 43.70%